Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

pfizer italia s.r.l. - quinapril e diuretici - quinapril e diuretici

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - polysaccharida streptococci pneumoniae typus 1, polysaccharida streptococci pneumoniae typus 2, polysaccharida streptococci pneumoniae typus 3, polysaccharida streptococci pneumoniae typus 4, polysaccharida streptococci pneumoniae typus 5, polysaccharida streptococci pneumoniae typus 6b, polysaccharida streptococci pneumoniae typus 7f, polysaccharida streptococci pneumoniae typus 8, polysaccharida streptococci pneumoniae typus 9n, polysaccharida streptococci pneumoniae typus 9v, polysaccharida streptococci - injektionslösung in einer durchstechflasche - polysaccharida streptococci pneumoniae typus 1 25 µg, polysaccharida streptococci pneumoniae typus 2 25 µg, polysaccharida streptococci pneumoniae typus 3 25 µg, polysaccharida streptococci pneumoniae typus 4 25 µg, polysaccharida streptococci pneumoniae typus 5 25 µg, polysaccharida streptococci pneumoniae typus 6b 25 µg, polysaccharida streptococci pneumoniae typus 7f 25 µg, polysaccharida streptococci pneumoniae typus 8 25 µg, polysaccharida streptococci pneumoniae typus 9n 25 µg, polysaccharida streptococci pneumoniae typus 9v 25 µg, polysaccharida streptococci pneumoniae typus 10a 25 µg, polysaccharida streptococci pneumoniae typus 11a 25 µg, polysaccharida streptococci pneumoniae typus 12f 25 µg, polysaccharida streptococci pneumoniae typus 14 25 µg, polysaccharida streptococci pneumoniae typus 15b 25 µg, polysaccharida streptococci pneumoniae typus 17f 25 µg, polysaccharida streptococci pneumoniae typus 18c 25 µg, polysaccharida streptococci pneumoniae typus 19a 25 µg, polysaccharida streptococci pneum - immunizzazione attiva contro le infezioni pneumococciche, in particolare, polmoniti, di età 2. anni - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

drossapharm ag - isotretinoinum - gel - isotretinoinum 0.5 mg, antiox.: e 321, excipiens annuncio gelatum pro 1 g. - akne vulgaris - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - polysaccharida streptococci pneumoniae typus 1 conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 4 conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 5 conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 6a conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 6b conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 7f conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 9v conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 14 conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 18c conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 19a conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 19f conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 23f conjugata cum proteino corynebacteriae diphtheriae crm 197 - sospensione iniettabile in una siringa preriempita - polysaccharida streptococci pneumoniae typus 1 conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg et polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg et polysaccharida streptococci pneumoniae typus 4 conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg et polysaccharida streptococci pneumoniae typus 5 conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg et polysaccharida streptococci pneumoniae typus 6a conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg et polysaccharida streptococci pneumoniae typus 6b conjugata cum proteino corynebacteriae diphtheriae crm 197 4.4 µg et polysaccharida streptococci pneumoniae typus 7f conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg et polysaccharida streptococci pneumoniae typus 9v conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg et polysaccharida streptococci pneumoniae typus 14 conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg et polysaccharida streptococci pneumoniae typus 18c conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg et polysaccharida streptococci pneumoniae typus 19a conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg et polysaccharida streptococci pneumoniae typus 19f conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg et polysaccharida streptococci pneumoniae typus 23f conjugata cum proteino corynebacteriae diphtheriae crm 197 2.2 µg corresp. polysaccharida 30.8 µg et proteinum corynebacteriae diphtheriae crm 197 ca. 32 µg, adjuvans: aluminium ut aluminii phosphas, natrii chloridum corresp. natrium 1.67 mg, acidum succinicum, polysorbatum 80, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml. - aktive immunisierung gegen pneumokokken-infektionen der serotypen 1, 3, 4, 5, 6a, 6b, 7f, 9v, 14, 18c, 19a, 19f, 23f - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - polysaccharida streptococci pneumoniae typus 1, polysaccharida streptococci pneumoniae typus 3, polysaccharida streptococci pneumoniae typus 4, polysaccharida streptococci pneumoniae typus 5, polysaccharida streptococci pneumoniae typus 6b, polysaccharida streptococci pneumoniae typus 7f, polysaccharida streptococci pneumoniae typus 8, polysaccharida streptococci pneumoniae typus 9n, polysaccharida streptococci pneumoniae typus 9v, polysaccharida streptococci pneumoniae typus 10a, polysaccharida streptococci pneumoniae typus 11a, polysaccharida streptococci pneumoniae typus 12f, polysaccharida streptococci pneumoniae typus 14, polysaccharida streptococci pneumoniae typus 15b, polysaccharida streptococci pneumoniae typus 17f, polysaccharida streptococci pneumoniae typus 20, polysaccharida streptococci pneumoniae typus 22f, polysaccharida streptococci pneumoniae typus 23f, polysaccharida streptococci pneumoniae typus 33f - soluzione iniettabile in siringa preriempita - polysaccharida streptococci pneumoniae typus 1 25 µg, polysaccharida streptococci pneumoniae typus 3 25 µg, polysaccharida streptococci pneumoniae typus 4 25 µg, polysaccharida streptococci pneumoniae typus 5 25 µg, polysaccharida streptococci pneumoniae typus 6b 25 µg, polysaccharida streptococci pneumoniae typus 7f 25 µg, polysaccharida streptococci pneumoniae typus 8 25 µg, polysaccharida streptococci pneumoniae typus 9n 25 µg, polysaccharida streptococci pneumoniae typus 9v 25 µg, polysaccharida streptococci pneumoniae typus 10a 25 µg, polysaccharida streptococci pneumoniae typus 11a 25 µg, polysaccharida streptococci pneumoniae typus 12f 25 µg, polysaccharida streptococci pneumoniae typus 14 25 µg, polysaccharida streptococci pneumoniae typus 15b 25 µg, polysaccharida streptococci pneumoniae typus 17f 25 µg, polysaccharida streptococci pneumoniae typus 20 25 µg, polysaccharida streptococci pneumoniae typus 22f 25 µg, polysaccharida streptococci pneumoniae typus 23f 25 µg, polysaccharida streptococci pneumoniae typus 33f 25 µg, natrii chloridum corresp. natrium 1.8 mg, phenolum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - immunizzazione attiva contro le infezioni pneumococciche, in particolare, polmoniti, di età 2. anni - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - polysaccharida streptococci pneumoniae typus 1, polysaccharida streptococci pneumoniae typus 2, polysaccharida streptococci pneumoniae typus 3, polysaccharida streptococci pneumoniae typus 4, polysaccharida streptococci pneumoniae typus 5, polysaccharida streptococci pneumoniae typus 6b, polysaccharida streptococci pneumoniae typus 7f, polysaccharida streptococci pneumoniae typus 8, polysaccharida streptococci pneumoniae typus 9n, polysaccharida streptococci pneumoniae typus 9v, polysaccharida streptococci - injektionslösung in einer durchstechflasche - polysaccharida streptococci pneumoniae typus 1 25 µg, polysaccharida streptococci pneumoniae typus 2 25 µg, polysaccharida streptococci pneumoniae typus 3 25 µg, polysaccharida streptococci pneumoniae typus 4 25 µg, polysaccharida streptococci pneumoniae typus 5 25 µg, polysaccharida streptococci pneumoniae typus 6b 25 µg, polysaccharida streptococci pneumoniae typus 7f 25 µg, polysaccharida streptococci pneumoniae typus 8 25 µg, polysaccharida streptococci pneumoniae typus 9n 25 µg, polysaccharida streptococci pneumoniae typus 9v 25 µg, polysaccharida streptococci pneumoniae typus 10a 25 µg, polysaccharida streptococci pneumoniae typus 11a 25 µg, polysaccharida streptococci pneumoniae typus 12f 25 µg, polysaccharida streptococci pneumoniae typus 14 25 µg, polysaccharida streptococci pneumoniae typus 15b 25 µg, polysaccharida streptococci pneumoniae typus 17f 25 µg, polysaccharida streptococci pneumoniae typus 18c 25 µg, polysaccharida streptococci pneumoniae typus 19a 25 µg, polysaccharida streptococci pneum - immunizzazione attiva contro le infezioni pneumococciche, in particolare, polmoniti, di età 2. anni - vaccini

Unione Europea - italiano - EMA (European Medicines Agency)

accord healthcare s.l.u. - cinacalcet cloridrato - iperparatiroidismo - omeostasi del calcio - secondaria hyperparathyroidismadultstreatment dell'iperparatiroidismo secondario (hpt) in pazienti adulti con malattia renale allo stadio terminale (esrd) manutenzione terapia di dialisi. pediatrica populationtreatment dell'iperparatiroidismo secondario (hpt) in bambini di età compresa tra 3 anni e anziani con malattia renale allo stadio terminale (esrd) manutenzione terapia di dialisi in cui hpt secondaria non è adeguatamente controllata con standard di cura terapia (vedere paragrafo 4. cinacalcet accordpharma può essere utilizzato come parte di un regime terapeutico tra leganti di fosfato e/o vitamina d steroli, come appropriato (vedere la sezione 5. carcinoma paratiroideo e iperparatiroidismo primario in adultsreduction di ipercalcemia in pazienti adulti con:carcinoma paratiroideo. primaria hpt per i quali parathyroidectomy sarebbe indicata sulla base dei livelli di calcio sierico (come definito dalle relative linee guida di trattamento), ma in cui la parathyroidectomy non è clinicamente appropriato o è controindicato.

Unione Europea - italiano - EMA (European Medicines Agency)

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - agenti antineoplastici - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase.  chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib.  ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib.  newly diagnosed ph+ all in combination with chemotherapy.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - polysaccharida neisseriae meningitidis a, polysaccharida neisseriae meningitidis c, polysaccharida neisseriae meningitidis y, toxoidum tetani - soluzione iniettabile - polysaccharida neisseriae meningitidis a 10 µg et polysaccharida neisseriae meningitidis c 10 µg et polysaccharida neisseriae meningitidis y 10 µg et polysaccharida neisseriae meningitidis w-135 10 µg conjugatum cum toxoidum tetani 55 µg, natrii chloridum, natrii acetas ut natrii acetas trihydricus et acidum aceticum glaciale, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 1.67 mg. - immunisation active contre la méningite à méningocoques des sérogroupes a, c, w135 et y - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - polysaccharida neisseriae meningitidis c (stamm c11, de-o-acetyliert) - sospensione iniettabile - polysaccharida neisseriae meningitidis c (stamm c11, de-o-acetyliert) 10 µg conjugatum cum toxoidum tetani 10-20 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, natrii chloridum corresp. natrium 1.6 mg, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml. - immunizzazione attiva contro l'infezione da meningococco di serogruppe c, di età 2. mese di vita - vaccini